Literature DB >> 29455411

Completion of Gamma Knife radiosurgery for AVM treatment after unplanned interruption-technical note.

Hari S Raman1, Lakshmi Santanam2, Ananth K Vellimana1, Robert E Drzymala2, Christina I Tsien2, Gregory J Zipfel3.   

Abstract

BACKGROUND AND IMPORTANCE: Gamma Knife radiosurgery is an established technique for non-urgent treatment of various intracranial pathologies. Intra-procedural dislodgement of the stereotactic frame is an uncommon occurrence that could lead to abortion of ongoing treatment and necessitate more invasive treatment strategies. CLINICAL
PRESENTATION: In this case report, we describe a novel method for resumption of Gamma Knife treatment after an unplanned intra-procedural interruption. The case example involves a radiosurgical treatment of a Spetzler-Martin grade I arteriovenous malformation.
CONCLUSION: Our technique involves integration of scans and coordinate systems from two imaging sessions using the composite isodose line to resolve translational differences, thereby limiting delivery of remaining shots to the untreated region of the lesion. MRI follow-up at 13 months showed a reduction in the nidus size with no evidence of any radiation injury to the surrounding brain parenchyma. We believe this technique will allow care teams to effectively salvage interrupted Gamma Knife procedures and reduce progression to more invasive treatment options.

Entities:  

Keywords:  AVM; Frame dislodgement; Gamma Knife; Radiosurgery

Mesh:

Year:  2018        PMID: 29455411      PMCID: PMC5997571          DOI: 10.1007/s00701-018-3493-0

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  8 in total

1.  A randomized trial of unruptured brain arteriovenous malformations.

Authors:  Robert M Starke; Ricardo J Komotar; E Sander Connolly
Journal:  Neurosurgery       Date:  2013-10       Impact factor: 4.654

2.  The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment.

Authors:  S L Ondra; H Troupp; E D George; K Schwab
Journal:  J Neurosurg       Date:  1990-09       Impact factor: 5.115

Review 3.  A comprehensive review of radiosurgery for cerebral arteriovenous malformations: outcomes, predictive factors, and grading scales.

Authors:  Robert M Starke; Ricardo J Komotar; Brian Y Hwang; Laura E Fischer; Marc L Otten; Maxwell B Merkow; Matthew C Garrett; Steven R Isaacson; E Sander Connolly
Journal:  Stereotact Funct Neurosurg       Date:  2008-04-18       Impact factor: 1.875

Review 4.  Gamma knife surgery for pediatric arteriovenous malformations: a review.

Authors:  Stephen James Monteith; Chun-Po Yen; Jason P Sheehan
Journal:  Clin Neurosurg       Date:  2011

5.  Predictors of hemorrhage in patients with untreated brain arteriovenous malformation.

Authors:  C Stapf; H Mast; R R Sciacca; J H Choi; A V Khaw; E S Connolly; J Pile-Spellman; J P Mohr
Journal:  Neurology       Date:  2006-05-09       Impact factor: 9.910

6.  Complications of Gamma Knife surgery: an early report from 2 Canadian centers.

Authors:  Shobhan Vachhrajani; Charbel Fawaz; David Mathieu; Cynthia Ménard; Michael D Cusimano; Fred Gentili; Mojgan Hodaie; Brendan Kenny; Abhaya V Kulkarni; Normand Laperriere; Michael Schwartz; May Tsao; Mark Bernstein
Journal:  J Neurosurg       Date:  2008-12       Impact factor: 5.115

7.  Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population.

Authors:  Alexander X Halim; S Claiborne Johnston; Vineeta Singh; Charles E McCulloch; John P Bennett; Achal S Achrol; Stephen Sidney; William L Young
Journal:  Stroke       Date:  2004-05-27       Impact factor: 7.914

8.  Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial.

Authors:  J P Mohr; Michael K Parides; Christian Stapf; Ellen Moquete; Claudia S Moy; Jessica R Overbey; Rustam Al-Shahi Salman; Eric Vicaut; William L Young; Emmanuel Houdart; Charlotte Cordonnier; Marco A Stefani; Andreas Hartmann; Rüdiger von Kummer; Alessandra Biondi; Joachim Berkefeld; Catharina J M Klijn; Kirsty Harkness; Richard Libman; Xavier Barreau; Alan J Moskowitz
Journal:  Lancet       Date:  2013-11-20       Impact factor: 79.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.